1. Home
  2. SONM vs ATHA Comparison

SONM vs ATHA Comparison

Compare SONM & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • ATHA
  • Stock Information
  • Founded
  • SONM 1999
  • ATHA 2011
  • Country
  • SONM United States
  • ATHA United States
  • Employees
  • SONM N/A
  • ATHA N/A
  • Industry
  • SONM Telecommunications Equipment
  • ATHA Medicinal Chemicals and Botanical Products
  • Sector
  • SONM Telecommunications
  • ATHA Health Care
  • Exchange
  • SONM Nasdaq
  • ATHA Nasdaq
  • Market Cap
  • SONM 10.2M
  • ATHA 10.6M
  • IPO Year
  • SONM 2019
  • ATHA 2020
  • Fundamental
  • Price
  • SONM $0.66
  • ATHA $0.34
  • Analyst Decision
  • SONM
  • ATHA Buy
  • Analyst Count
  • SONM 0
  • ATHA 4
  • Target Price
  • SONM N/A
  • ATHA $11.25
  • AVG Volume (30 Days)
  • SONM 12.3M
  • ATHA 221.9K
  • Earning Date
  • SONM 08-08-2025
  • ATHA 07-31-2025
  • Dividend Yield
  • SONM N/A
  • ATHA N/A
  • EPS Growth
  • SONM N/A
  • ATHA N/A
  • EPS
  • SONM N/A
  • ATHA N/A
  • Revenue
  • SONM $58,243,000.00
  • ATHA N/A
  • Revenue This Year
  • SONM $127.68
  • ATHA N/A
  • Revenue Next Year
  • SONM N/A
  • ATHA N/A
  • P/E Ratio
  • SONM N/A
  • ATHA N/A
  • Revenue Growth
  • SONM N/A
  • ATHA N/A
  • 52 Week Low
  • SONM $0.60
  • ATHA $0.22
  • 52 Week High
  • SONM $9.21
  • ATHA $3.67
  • Technical
  • Relative Strength Index (RSI)
  • SONM 39.12
  • ATHA 47.50
  • Support Level
  • SONM $0.60
  • ATHA $0.29
  • Resistance Level
  • SONM $2.08
  • ATHA $0.32
  • Average True Range (ATR)
  • SONM 0.32
  • ATHA 0.02
  • MACD
  • SONM -0.07
  • ATHA -0.00
  • Stochastic Oscillator
  • SONM 4.48
  • ATHA 17.85

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: